BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 1901381)

  • 1. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Kitamura D; Roes J; Kühn R; Rajewsky K
    Nature; 1991 Apr; 350(6317):423-6. PubMed ID: 1901381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell development in mice with a defective lambda 5 gene.
    Rolink A; Karasuyama H; Grawunder U; Haasner D; Kudo A; Melchers F
    Eur J Immunol; 1993 Jun; 23(6):1284-8. PubMed ID: 7684685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion.
    Kitamura D; Rajewsky K
    Nature; 1992 Mar; 356(6365):154-6. PubMed ID: 1545868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo generation of murine IgD-secreting cells is accompanied by deletion of the C mu gene and occasional deletion of the gene for the C delta 1 domain.
    Mountz JD; Mushinski JF; Owens JD; Finkelman FD
    J Immunol; 1990 Sep; 145(5):1583-91. PubMed ID: 1696602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pre-B-cell receptor.
    Mårtensson IL; Keenan RA; Licence S
    Curr Opin Immunol; 2007 Apr; 19(2):137-42. PubMed ID: 17306522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel B cell population producing functional IgG in the absence of membrane IgM expression.
    Orinska Z; Osiak A; Löhler J; Bulanova E; Budagian V; Horak I; Bulfone-Paus S
    Eur J Immunol; 2002 Dec; 32(12):3472-80. PubMed ID: 12442329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the rearrangement of immunoglobulin genes, the appearance of a B lymphocyte antigen, and immunoglobulin synthesis in murine pre-B cell lines.
    Sugiyama H; Akira S; Yoshida N; Kishimoto S; Yamamura Y; Kincade P; Honjo T; Kishimoto T
    J Immunol; 1982 Jun; 128(6):2793-7. PubMed ID: 6281337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
    Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
    Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor B cells of mouse bone marrow express two different complexes with the surrogate light chain on the surface.
    Winkler TH; Rolink A; Melchers F; Karasuyama H
    Eur J Immunol; 1995 Feb; 25(2):446-50. PubMed ID: 7875207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In rat B lymphocyte genesis sixty percent is lost from the bone marrow at the transition of nondividing pre-B cell to sIgM+ B lymphocyte, the stage of Ig light chain gene expression.
    Deenen GJ; Van Balen I; Opstelten D
    Eur J Immunol; 1990 Mar; 20(3):557-64. PubMed ID: 2108044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic exclusion in transgenic mice expressing a heavy chain disease-like human mu protein.
    Corcos D; Iglesias A; Dunda O; Bucchini D; Jami J
    Eur J Immunol; 1991 Nov; 21(11):2711-6. PubMed ID: 1936120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early B cell development requires mu signaling.
    Iglesias A; Nichogiannopoulou A; Williams GS; Flaswinkel H; Köhler G
    Eur J Immunol; 1993 Oct; 23(10):2622-30. PubMed ID: 8405063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surrogate light chain in B-cell development.
    Melchers F; Karasuyama H; Haasner D; Bauer S; Kudo A; Sakaguchi N; Jameson B; Rolink A
    Immunol Today; 1993 Feb; 14(2):60-8. PubMed ID: 8166770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.